"There isn't, and it is unlikely there ever will be, a single approach to long COVID. It's very much about personalised medicine."
James Chalmers steps away from the ERJ briefly to discuss the recent Monograph on "COVID-19: An Update", which he co-Guest Edited with Catia Cilloniz and Bin Cao. Dorina Esendagli (the Monograph's Early Career Member representat ... Show More
Sep 15
ERJ Podcast August 2025: Treatment of central sleep apnoea with adaptive servo-ventilation
As part of the August issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Winfried Randerath (Bethanien Hospital, Clinic of Pneumology and Allergology, Centre for Sleep Medicine and Respiratory Care, Instit ... Show More
11m 47s
Dec 2024
Science’s Breakthrough of the Year, and psychedelic drugs, climate, and fusion technology updates
First up this week, Breakthroughs Editor Greg Miller joins producer Meagan Cantwell to discuss Science’s 2024 Breakthrough of the Year. They also discuss some of the other scientific achievements that turned heads this year, from ancient DNA and autoimmune therapy, to precision p ... Show More
45m 46s
Sep 2024
Updates in Canine Melanoma with Dr. Fan
Melanoma is a commonly encountered, often metastatic, disease in canine patients. In this episode of Clinician’s Brief Partner Podcast, Dr. Beth invites Dr. Timothy Fan to share advice on the clinical management of melanoma in practice. Dr. Fans offers insights on staging, surgic ... Show More
35m 51s
May 2020
New Chemo - Free Immunotherapy Options For NSCLC
There are 2 new Immunotherapy (without chemo) options for untreated metastatic NSCLC. We try to make sense of this evolving landscape. Then, we run through the latest TKI, ripretinib. Finally, we discuss a new approval for Kaposi sarcoma and our obligatory PARP inhibitors update ... Show More
16m 29s
Feb 2022
COVID-19 Associated Pulmonary Aspergillosis - The Other CAPA (JCM ed.)
When most of us hear the word ‘CAPA’, these days we more than likely immediately start thinking about SARS-CoV-2 variants, trying to remember how important this particular one was in the grand scheme of the COVID-19 pandemic. But, that is not the ‘kappa’ we will be talking about ... Show More
46m 15s
Aug 14
11: Navigating the Evolving Second-Line Landscape of Metastatic Urothelial Carcinoma
The latest Oncology Decoded discussion with Manojkumar Bupathi, MD, MS, executive cochair of the Genitourinary Cancer Research Executive Committee at Sarah Cannon Research Institute (SCRI) and medical oncologist with Rocky Mountain Cancer Centers specializing in solid tumors and ... Show More
41m 45s